10 November 2026 in Food Science & Nutrition
Abdominal aortic aneurysm (AAA) is a fatal inflammatory vascular disease without effective clinical treatments. Dietary patterns regulate aortic inflammation, and Mediterranean diet‐derived omega‐3 polyunsaturated fatty acids (ω‐3 PUFA) exert anti‐inflammatory effects, yet their cellular targets in AAA remain unclear. We integrated three single‐cell RNA‐seq cohorts (12 AAA, 3 controls) and constructed a human aortic cell atlas with 64,258 cells. Pseudo‐bulk analysis and CoVarNet multicellular network analysis revealed a core remodeling axis: protective FOLR2 + resident macrophages were depleted, while a unique AAA‐enriched NLRP3 + inflammatory macrophage population (M08_Mph_NLRP3) formed the hub of pathological inflammatory networks. Three bulk transcriptomic cohorts and five complementary enrichment approaches verified this signature. An LPS/OX‐LDL/IL‐1β‐stimulated THP‐1 model recapitulated AAA macrophage pathological changes including NLRP3 inflammasome overactivation, enhanced proliferation and migration. Further functional tests demonstrated ω‐3 PUFA markedly blocked inflammasome cascade, reduced IL‐1β/IL‐18 release and reversed all macrophage pathological phenotypes. This study identifies M08_Mph_NLRP3 as the important inflammatory mediator of AAA and provides single‐cell and in vitro functional evidence supporting ω‐3 PUFA as a candidate nutritional agent targeting NLRP3‐driven vascular inflammation.
1 January 2026 in Human Mutation
Neuroblastoma is a pediatric malignancy characterized by significant clinical heterogeneity. Although MYCN amplification is a well‐established marker of high‐risk disease, its interplay with the tumor immune microenvironment—particularly tumor‐associated macrophages (TAMs)—remains poorly understood. In this study, we developed an integrated gene signature incorporating genes associated with both MYCN amplification status and TAM infiltration, leading to the identification of 16 differentially expressed genes implicated in both biological processes. Six of these genes (CMBL, LY6E, KLRB1, CTSH, CD3D, and PTGDS) were utilized to construct a risk‐scoring model that effectively stratified neuroblastoma patients into high‐ and low‐risk groups with significantly distinct clinical outcomes ( p < 0.001). Notably, LY6E emerged as the most prognostically significant gene within the signature. More importantly, we revealed that LY6E modulates M2‐type macrophage polarization in neuroblastoma for the first time, suggesting a novel mechanism through which it may contribute to shaping an immunosuppressive tumor microenvironment.